Orchid Chemicals & Pharmaceuticals Ltd said it has received a tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for its generic drug Gemifloxacin Mesylate tablets in 320 mg strength.
Gemifloxacin Mesylate is an oral broad-spectrum quinolone antibacterial agent used in the treatment of acute bacterial exacerbation of chronic bronchitis and mild-to-moderate pneumonia.
On Monday, Orchid Chemicals shares closed 1.82% up at Rs173 on the Bombay Stock Exchange, while the Sensex ended at 0.11% down at 17,441 points.
Four Soft, which offers software solutions for logistics and transportation industry, has won a deal from Aries Global Logistics, a US based freight forwarding and custom brokerage company, to implement its global freight forwarding application 4S eTrans and partner in developing 4S eCustoms for US imports and several other import related modules. No price details of the deal were provided.
The contract has been executed through Four Soft USA Inc, a subsidiary of Four Soft, India. 4S eCustoms is the first integrated global solution for customs compliance integrating multiple country customs brokerage into one framework.
With the addition of US imports 4S will be the largest licensed software provider for customs compliance with a significant percentage of world transactions being processed through 4S systems.
On Monday, Four Soft shares closed 1.53% down at Rs22 on the Bombay Stock Exchange, while the Sensex ended at 0.11% down at 17,441 points.